Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
8000 participants
OBSERVATIONAL
2025-12-31
2036-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study aims to:
1. To compile detailed demographic information of patients with PC.
2. To document and analyze the clinical and disease characteristics at the time of diagnosis and beyond.
3. To track various treatment modalities employed, including surgery, chemotherapy, and radiation therapy.
4. To assess short-term and long-term outcomes, including survival rates, complications, and quality of life.
5. To identify prognostic and predictive factors within the real-world cohort.
8\. To investigate the impact of PC and treatment on patients' quality of life.
4 Study Design This study of patients with PC will employ both a prospective, observational design and retrospective design to capture real-world data relating to health status and/or the delivery of health care routinely collected from a variety of sources. Data will be collected longitudinally, allowing for a dynamic analysis of the disease trajectory.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with PC are referred to Comprehensive Pancreatic Cancer Center at Herlev Hospital
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inna Chen, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Inna Chen, MD
MD
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Inna Markovna Inna Markovna Chen, MD, Herlev & Gentofte Hospital, MD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PA2416
Identifier Type: -
Identifier Source: org_study_id